Landscape of 2D Deep Learning Segmentation Networks Applied to CT Scan from Lung Cancer Patients: A Systematic Review
Somayeh Sadat Mehrnia,
No information about this author
Zhino Safahi,
No information about this author
Amin Mousavi
No information about this author
et al.
Deleted Journal,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 4, 2025
The
increasing
rates
of
lung
cancer
emphasize
the
need
for
early
detection
through
computed
tomography
(CT)
scans,
enhanced
by
deep
learning
(DL)
to
improve
diagnosis,
treatment,
and
patient
survival.
This
review
examines
current
prospective
applications
2D-
DL
networks
in
CT
segmentation,
summarizing
research,
highlighting
essential
concepts
gaps;
Methods:
Following
Preferred
Reporting
Items
Systematic
Reviews
Meta-Analysis
guidelines,
a
systematic
search
peer-reviewed
studies
from
01/2020
12/2024
on
data-driven
population
segmentation
using
structured
data
was
conducted
across
databases
like
Google
Scholar,
PubMed,
Science
Direct,
IEEE
(Institute
Electrical
Electronics
Engineers)
ACM
(Association
Computing
Machinery)
library.
124
met
inclusion
criteria
were
analyzed.
LIDC-LIDR
dataset
most
frequently
used;
finding
particularly
relies
supervised
with
labeled
data.
UNet
model
its
variants
used
models
medical
image
achieving
Dice
Similarity
Coefficients
(DSC)
up
0.9999.
reviewed
primarily
exhibit
significant
gaps
addressing
class
imbalances
(67%),
underuse
cross-validation
(21%),
poor
stability
evaluations
(3%).
Additionally,
88%
failed
address
missing
data,
generalizability
concerns
only
discussed
34%
cases.
emphasizes
importance
Convolutional
Neural
Networks,
UNet,
analysis
advocates
combined
2D/3D
modeling
approach.
It
also
highlights
larger,
diverse
datasets
exploration
semi-supervised
unsupervised
enhance
automated
diagnosis
detection.
Language: Английский
Development and validation of machine learning models based on molecular features for estimating the probability of multiple primary lung carcinoma versus intrapulmonary metastasis in patients presenting multiple non-small cell lung cancers
Ning Liu,
No information about this author
Xue Li,
No information about this author
Luo Xu
No information about this author
et al.
Translational Lung Cancer Research,
Journal Year:
2025,
Volume and Issue:
14(4), P. 1118 - 1137
Published: April 1, 2025
Discrimination
of
multiple
non-small
cell
lung
cancers
(NSCLCs)
as
primary
(MPLCs)
or
intrapulmonary
metastases
(IPMs)
is
critical
but
remains
challenging.
The
aim
this
study
to
develop
and
validate
the
machine
learning
(ML)
models
based
on
molecular
features
for
estimating
probability
MPLC
IPM
patients
presenting
NSCLCs.
A
total
72
NSCLCs
with
157
surgical
resection
tumor
lesions
from
January
2012
2018
at
two
institutions
were
included
developing
testing
models.
Specifically,
46
103
tumors
which
defined
definitive
according
International
Association
Study
Lung
Cancer
(IASLC)
criteria
used
They
spilt
into
training
validation
sets
using
stratified
random
sampling
five-fold
cross-validation.
developed
tested
in
other
26
whose
undetermined
by
traditional
methods.
Whole-exome
sequencing
(WES)
was
performed
all
samples.
Four
calculated
characterize
relatedness
served
model
inputs,
including
genetic
divergence,
shared
mutation
number,
Pearson
correlation
coefficient
early
number.
Decision
trees
(DT),
forests
(RF),
gradient
boosting
decision
(GBDT)
employed,
performance
assessed
areas
under
curve
(AUCs),
accuracy,
precision,
recall,
F1
score
set.
Disease-free
survival
(DFS)
evaluate
test
cohort.
Clinical
characteristics
then
compared
between
populations.
All
four
showed
significant
differences
development
That
is,
exhibited
higher
lower
number
than
(P<0.001).
DT
model,
RF
GBDT
these
factors
achieved
a
mean
AUC
0.94
[standard
deviation
(SD)
0.09],
1.00
(SD
0.00)
set,
respectively.
discriminated
(n=15)
(n=11)
consistently.
identified
ML
had
significantly
prolonged
DFS
[hazard
ratio
=0.21;
95%
confidence
interval
(CI):
0.04-1.0;
P=0.04]
that
IPM.
relative
prevalence
family
history
first-degree
relatives
cancer,
more
half
reported
cancer.
EGFR
most
common
mutated
driver
both
effectively
distcriminate
NSCLCs,
improve
accuracy
diagnosis
assist
clinical
decision-making,
particularly
challenging
cases.
Language: Английский